{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T17:17:55Z","timestamp":1790183875614,"version":"4.1.0"},"reference-count":80,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Chest Medicine"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.ccm.2013.08.003","type":"journal-article","created":{"date-parts":[[2013,11,21]],"date-time":"2013-11-21T16:52:21Z","timestamp":1385052741000},"page":"651-663","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Genetics of Pulmonary Arterial Hypertension"],"prefix":"10.1016","volume":"34","author":[{"given":"C. Gregory","family":"Elliott","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ccm.2013.08.003_bib1","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1378\/chest.104.1.236","article-title":"Primary pulmonary hypertension","volume":"104","author":"Rubin","year":"1993","journal-title":"Chest"},{"issue":"16","key":"10.1016\/j.ccm.2013.08.003_bib2","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1161\/CIRCULATIONAHA.109.192230","volume":"119","author":"McLaughlin","year":"2009","journal-title":"Circulation"},{"issue":"Suppl 1","key":"10.1016\/j.ccm.2013.08.003_bib3","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1016\/j.jacc.2009.04.011","article-title":"Diagnosis and assessment of pulmonary arterial hypertension","volume":"54","author":"Badesch","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"Suppl 1","key":"10.1016\/j.ccm.2013.08.003_bib4","doi-asserted-by":"crossref","first-page":"35S","DOI":"10.1378\/chest.126.1_suppl.35S","article-title":"Medical therapy for pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines","volume":"126","author":"Badesch","year":"2004","journal-title":"Chest"},{"issue":"Suppl 1","key":"10.1016\/j.ccm.2013.08.003_bib5","doi-asserted-by":"crossref","first-page":"S78","DOI":"10.1016\/j.jacc.2009.04.017","article-title":"Updated evidence-based treatment algorithm in pulmonary arterial hypertension","volume":"54","author":"Barst","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.ccm.2013.08.003_bib6","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1056\/NEJM199207093270203","article-title":"The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension","volume":"327","author":"Rich","year":"1992","journal-title":"N\u00a0Engl J Med"},{"issue":"23","key":"10.1016\/j.ccm.2013.08.003_bib7","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.1161\/CIRCULATIONAHA.104.488486","article-title":"Long-term response to calcium channel blockers in idiopathic pulmonary arterial hypertension","volume":"111","author":"Sitbon","year":"2005","journal-title":"Circulation"},{"issue":"Suppl 1","key":"10.1016\/j.ccm.2013.08.003_bib8","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1016\/j.jacc.2009.04.012","article-title":"Updated clinical classification of pulmonary hypertension","volume":"54","author":"Simonneau","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.ccm.2013.08.003_bib9","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1086\/303059","article-title":"Familial primary pulmonary hypertension (gene PPH1) is caused by mutations in the bone morphogenetic protein receptor-II gene","volume":"67","author":"Deng","year":"2000","journal-title":"Am J Hum Genet"},{"issue":"1","key":"10.1016\/j.ccm.2013.08.003_bib10","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/79226","article-title":"Heterozygous germline mutations in BMPR2, encoding a TGF-beta receptor, cause familial primary pulmonary hypertension. The International PPH Consortium","volume":"26","author":"Lane","year":"2000","journal-title":"Nat Genet"},{"issue":"5","key":"10.1016\/j.ccm.2013.08.003_bib11","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1056\/NEJM200108023450503","article-title":"Clinical and molecular genetic features of pulmonary hypertension in patients with hereditary hemorrhagic telangiectasia","volume":"345","author":"Trembath","year":"2001","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.ccm.2013.08.003_bib12","first-page":"195","article-title":"Recent studies in primary pulmonary hypertension, including pharmacodynamic observations on pulmonary vascular resistance","volume":"30","author":"Dresdale","year":"1954","journal-title":"Bull N Y Acad Med"},{"issue":"1","key":"10.1016\/j.ccm.2013.08.003_bib13","first-page":"194","article-title":"Familial primary pulmonary hypertension: clinical patterns","volume":"129","author":"Loyd","year":"1984","journal-title":"Am Rev Respir Dis"},{"issue":"9","key":"10.1016\/j.ccm.2013.08.003_bib14","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1164\/rccm.201205-0886OC","article-title":"Longitudinal analysis casts doubt on the presence of genetic anticipation in heritable pulmonary arterial hypertension","volume":"186","author":"Larkin","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.ccm.2013.08.003_bib15","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1164\/ajrccm.152.1.7599869","article-title":"Genetic anticipation and abnormal gender ratio at birth in familial primary pulmonary hypertension","volume":"152","author":"Loyd","year":"1995","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ccm.2013.08.003_bib16","series-title":"The pulmonary circulation: normal and abnormal","first-page":"301","article-title":"Familial pulmonary hypertension","author":"Newman","year":"1990"},{"key":"10.1016\/j.ccm.2013.08.003_bib17","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1378\/chest.108.4.973","article-title":"Coancestry in apparently sporadic primary pulmonary hypertension","volume":"108","author":"Elliott","year":"1995","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.ccm.2013.08.003_bib18","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1056\/NEJM200108023450502","article-title":"Mutation in the gene for bone morphogenetic protein receptor ii as a cause of primary pulmonary hypertension in a large kindred","volume":"345","author":"Newman","year":"2001","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.ccm.2013.08.003_bib19","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/ng0397-277","article-title":"Localization of the gene for familial primary pulmonary hypertension to chromosome 2q31-32","volume":"15","author":"Nichols","year":"1997","journal-title":"Nat Genet"},{"issue":"12","key":"10.1016\/j.ccm.2013.08.003_bib20","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1161\/01.CIR.95.12.2603","article-title":"Mapping of familial primary pulmonary hypertension locus (PPH1) to chromosome 2q31-q32","volume":"95","author":"Morse","year":"1997","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.ccm.2013.08.003_bib21","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1186\/rr57","article-title":"Bone morphogenetic proteins, genetics and the pathophysiology of primary pulmonary hypertension","volume":"2","author":"De Caestecker","year":"2001","journal-title":"Respir Res"},{"issue":"Suppl 1","key":"10.1016\/j.ccm.2013.08.003_bib22","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1016\/j.jacc.2009.04.015","article-title":"Genetics and genomics of pulmonary arterial hypertension","volume":"54","author":"Machado","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"10","key":"10.1016\/j.ccm.2013.08.003_bib23","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1136\/jmg.37.10.741","article-title":"Sporadic primary pulmonary hypertension is associated with germline mutations of the gene encoding BMPR-II, a receptor member of the TGF-beta family","volume":"37","author":"Thomson","year":"2000","journal-title":"J\u00a0Med Genet"},{"issue":"1","key":"10.1016\/j.ccm.2013.08.003_bib24","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1086\/316947","article-title":"BMPR2 haploinsufficiency as the inherited molecular mechanism for primary pulmonary hypertension","volume":"68","author":"Machado","year":"2001","journal-title":"Am J Hum Genet"},{"issue":"2","key":"10.1016\/j.ccm.2013.08.003_bib25","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1002\/humu.9398","article-title":"BMPR2 gene rearrangements account for a significant proportion of mutations in familial and idiopathic pulmonary arterial hypertension","volume":"27","author":"Aldred","year":"2006","journal-title":"Hum Mutat"},{"issue":"2","key":"10.1016\/j.ccm.2013.08.003_bib26","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/humu.20285","article-title":"Mutations of the TGF-beta type II receptor BMPR2 in pulmonary arterial hypertension","volume":"27","author":"Machado","year":"2006","journal-title":"Hum Mutat"},{"issue":"3","key":"10.1016\/j.ccm.2013.08.003_bib27","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/01.GIM.0000156525.09595.E9","article-title":"Gross BMPR2 gene rearrangements constitute a new cause for primary pulmonary hypertension","volume":"7","author":"Cogan","year":"2005","journal-title":"Genet Med"},{"issue":"5","key":"10.1016\/j.ccm.2013.08.003_bib28","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1164\/rccm.200602-165OC","article-title":"High frequency of BMPR2 exonic deletions\/duplications in familial pulmonary arterial hypertension","volume":"174","author":"Cogan","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"issue":"8","key":"10.1016\/j.ccm.2013.08.003_bib29","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1164\/rccm.200701-164OC","article-title":"Characterization of the BMPR2 5'-untranslated region and a novel mutation in pulmonary hypertension","volume":"176","author":"Aldred","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"issue":"12 Suppl S","key":"10.1016\/j.ccm.2013.08.003_bib30","doi-asserted-by":"crossref","first-page":"13S","DOI":"10.1016\/j.jacc.2004.02.029","article-title":"Cellular and molecular pathobiology of pulmonary arterial hypertension","volume":"43","author":"Humbert","year":"2004","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.ccm.2013.08.003_bib31","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1513\/pats.201002-024AW","article-title":"Bone morphogenetic protein type II receptor mutations causing protein misfolding in heritable pulmonary arterial hypertension","volume":"7","author":"Li","year":"2010","journal-title":"Proc Am Thorac Soc"},{"issue":"4","key":"10.1016\/j.ccm.2013.08.003_bib32","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1183\/09031936.00030312","article-title":"A\u00a0potential role for insulin resistance in experimental pulmonary hypertension","volume":"41","author":"West","year":"2013","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ccm.2013.08.003_bib33","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/1465-9921-11-73","article-title":"Absence of influence of gender and BMPR2 mutation type on clinical phenotypes of pulmonary arterial hypertension","volume":"11","author":"Girerd","year":"2010","journal-title":"Respir Res"},{"issue":"12","key":"10.1016\/j.ccm.2013.08.003_bib34","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1164\/rccm.200712-1807OC","article-title":"Clinical outcomes of pulmonary arterial hypertension in carriers of BMPR2 mutation","volume":"177","author":"Sztrymf","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ccm.2013.08.003_bib35","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/1465-9921-12-99","article-title":"Hemodynamic and clinical onset in patients with hereditary pulmonary arterial hypertension and BMPR2 mutations","volume":"12","author":"Pfarr","year":"2011","journal-title":"Respir Res"},{"issue":"21","key":"10.1016\/j.ccm.2013.08.003_bib36","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1161\/CIRCULATIONAHA.105.601930","article-title":"Relationship of BMPR2 mutations to vasoreactivity in pulmonary arterial hypertension","volume":"113","author":"Elliott","year":"2006","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.ccm.2013.08.003_bib37","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.healun.2008.02.009","article-title":"Clinical implications of determining BMPR2 mutation status in a large cohort of children and adults with pulmonary arterial hypertension","volume":"27","author":"Rosenzweig","year":"2008","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.ccm.2013.08.003_bib38","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/1465-9921-10-87","article-title":"Truncating and missense BMPR2 mutations differentially affect the severity of heritable pulmonary arterial hypertension","volume":"10","author":"Austin","year":"2009","journal-title":"Respir Res"},{"issue":"4","key":"10.1016\/j.ccm.2013.08.003_bib39","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/0092-8674(93)90488-C","article-title":"Identification of human activin and TGF beta type I receptors that form heteromeric kinase complexes with type II receptors","volume":"75","author":"Attisano","year":"1993","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.ccm.2013.08.003_bib40","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1006\/bbrc.1995.2594","article-title":"Cloning and characterization of the murine activin receptor like kinase-1 (ALK-1) homolog","volume":"216","author":"Wu","year":"1995","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.ccm.2013.08.003_bib41","doi-asserted-by":"crossref","unstructured":"Favaro JP, Wiley K, Blobe GC. Alk1. UCSD-Nature Molecule Pages. 2005. http:\/\/dx.doi.org\/10.1038\/mp.a000254.000201.","DOI":"10.1038\/mp.a000254.01"},{"issue":"5155","key":"10.1016\/j.ccm.2013.08.003_bib42","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1126\/science.8140412","article-title":"Characterization of type I receptors for transforming growth factor-beta and activin","volume":"264","author":"ten Dijke","year":"1994","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.ccm.2013.08.003_bib43","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1136\/jmg.2005.030833","article-title":"Hereditary haemorrhagic telangiectasia: current views on genetics and mechanisms of disease","volume":"43","author":"Abdalla","year":"2006","journal-title":"J\u00a0Med Genet"},{"issue":"4","key":"10.1016\/j.ccm.2013.08.003_bib44","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1161\/01.CIR.0000153798.78540.87","article-title":"Transforming growth factor-beta receptor mutations and pulmonary arterial hypertension in childhood","volume":"111","author":"Harrison","year":"2005","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.ccm.2013.08.003_bib45","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1164\/rccm.200908-1284OC","article-title":"Clinical outcomes of pulmonary arterial hypertension in patients carrying an ACVRL1 (ALK1) mutation","volume":"181","author":"Girerd","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"issue":"12","key":"10.1016\/j.ccm.2013.08.003_bib46","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1136\/jmg.40.12.865","article-title":"Molecular and functional analysis identifies ALK-1 as the predominant cause of pulmonary hypertension related to hereditary haemorrhagic telangiectasia","volume":"40","author":"Harrison","year":"2003","journal-title":"J\u00a0Med Genet"},{"issue":"5","key":"10.1016\/j.ccm.2013.08.003_bib47","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1136\/thx.2003.11890","article-title":"Endoglin germline mutation in a patient with hereditary haemorrhagic telangiectasia and dexfenfluramine associated pulmonary arterial hypertension","volume":"59","author":"Chaouat","year":"2004","journal-title":"Thorax"},{"issue":"3","key":"10.1016\/j.ccm.2013.08.003_bib48","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.jmb.2006.10.015","article-title":"Structural model of human endoglin, a transmembrane receptor responsible for hereditary hemorrhagic telangiectasia","volume":"365","author":"Llorca","year":"2007","journal-title":"J\u00a0Mol Biol"},{"key":"10.1016\/j.ccm.2013.08.003_bib49","doi-asserted-by":"crossref","unstructured":"Ray B, Blobe GC. Endoglin. UCSD-Nature Molecule Pages. 2005. http:\/\/dx.doi.org\/10.1038\/mp.a000048.000001.","DOI":"10.1038\/mp.a000048.01"},{"issue":"6","key":"10.1016\/j.ccm.2013.08.003_bib50","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.blre.2010.07.001","article-title":"Hereditary haemorrhagic telangiectasia: pathophysiology, diagnosis and treatment","volume":"24","author":"Shovlin","year":"2010","journal-title":"Blood Rev"},{"issue":"5","key":"10.1016\/j.ccm.2013.08.003_bib51","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1136\/jmg.2008.062703","article-title":"A\u00a0new nonsense mutation of SMAD8 associated with pulmonary arterial hypertension","volume":"46","author":"Shintani","year":"2009","journal-title":"J\u00a0Med Genet"},{"issue":"6","key":"10.1016\/j.ccm.2013.08.003_bib52","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1253\/circj.CJ-11-1281","article-title":"Missense mutations of the BMPR1B (ALK6) gene in childhood idiopathic pulmonary arterial hypertension","volume":"76","author":"Chida","year":"2012","journal-title":"Circ J"},{"issue":"10","key":"10.1016\/j.ccm.2013.08.003_bib53","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1161\/01.RES.0000166926.54293.68","article-title":"Dysfunctional smad signaling contributes to abnormal smooth muscle cell proliferation in familial pulmonary arterial hypertension","volume":"96","author":"Yang","year":"2005","journal-title":"Circ Res"},{"issue":"3","key":"10.1016\/j.ccm.2013.08.003_bib54","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1161\/CIRCGENETICS.111.961888","article-title":"Whole exome sequencing to identify a novel gene (caveolin-1) associated with human pulmonary arterial hypertension","volume":"5","author":"Austin","year":"2012","journal-title":"Circ Cardiovasc Genet"},{"issue":"9","key":"10.1016\/j.ccm.2013.08.003_bib55","doi-asserted-by":"crossref","first-page":"6727","DOI":"10.1074\/jbc.M008340200","article-title":"Caveolin-1 regulates transforming growth factor (TGF)-beta\/SMAD signaling through an interaction with the TGF-beta type I receptor","volume":"276","author":"Razani","year":"2001","journal-title":"J\u00a0Biol Chem"},{"issue":"5","key":"10.1016\/j.ccm.2013.08.003_bib56","doi-asserted-by":"crossref","first-page":"L865","DOI":"10.1152\/ajplung.00079.2007","article-title":"Increased pulmonary vascular resistance and defective pulmonary artery filling in caveolin-1-\/- mice","volume":"294","author":"Maniatis","year":"2008","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.ccm.2013.08.003_bib57","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1056\/NEJMoa1211097","article-title":"A novel channelopathy in pulmonary arterial hypertension","volume":"369","author":"Ma","year":"2013","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.ccm.2013.08.003_bib58","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S1537-1891(02)00123-4","article-title":"Role of K+ channels in pulmonary hypertension","volume":"38","author":"Mandegar","year":"2002","journal-title":"Vascul Pharmacol"},{"issue":"5","key":"10.1016\/j.ccm.2013.08.003_bib59","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/ng.2581","article-title":"Genome-wide association analysis identifies a susceptibility locus for pulmonary arterial hypertension","volume":"45","author":"Germain","year":"2013","journal-title":"Nat Genet"},{"issue":"2","key":"10.1016\/j.ccm.2013.08.003_bib60","doi-asserted-by":"crossref","first-page":"216","DOI":"10.7326\/0003-4819-107-2-216","article-title":"Primary pulmonary hypertension: a national prospective study","volume":"107","author":"Rich","year":"1987","journal-title":"Ann Intern Med"},{"issue":"9","key":"10.1016\/j.ccm.2013.08.003_bib61","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1164\/rccm.200510-1668OC","article-title":"Pulmonary arterial hypertension in France: results from a National Registry","volume":"173","author":"Humbert","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.ccm.2013.08.003_bib62","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1378\/chest.09-1140","article-title":"Pulmonary arterial hypertension: baseline characteristics from the REVEAL Registry","volume":"137","author":"Badesch","year":"2010","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.ccm.2013.08.003_bib63","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1183\/09031936.02.01762002","article-title":"BMPR2 germline mutations in pulmonary hypertension associated with fenfluramine derivatives","volume":"20","author":"Humbert","year":"2002","journal-title":"Eur Respir J"},{"issue":"3","key":"10.1016\/j.ccm.2013.08.003_bib64","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1183\/09031936.04.00018604","article-title":"BMPR2 mutations in pulmonary arterial hypertension with congenital heart disease","volume":"24","author":"Roberts","year":"2004","journal-title":"Eur Respir J"},{"issue":"11","key":"10.1016\/j.ccm.2013.08.003_bib65","first-page":"2379","article-title":"Pulmonary hypertension in scleroderma spectrum of disease: lack of bone morphogenetic protein receptor 2 mutations","volume":"29","author":"Morse","year":"2002","journal-title":"J\u00a0Rheumatol"},{"issue":"10","key":"10.1016\/j.ccm.2013.08.003_bib66","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1002\/art.10487","article-title":"Mutations of bone morphogenetic protein receptor type II are not found in patients with pulmonary hypertension and underlying connective tissue diseases","volume":"46","author":"Tew","year":"2002","journal-title":"Arthritis Rheum"},{"issue":"10","key":"10.1016\/j.ccm.2013.08.003_bib67","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1164\/rccm.200204-330OC","article-title":"Prognostic factors for survival in human immunodeficiency virus-associated pulmonary arterial hypertension","volume":"167","author":"Nunes","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"issue":"9","key":"10.1016\/j.ccm.2013.08.003_bib68","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1164\/rccm.200809-1472OC","article-title":"Genetic risk factors for portopulmonary hypertension in patients with advanced liver disease","volume":"179","author":"Roberts","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.ccm.2013.08.003_bib69","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1183\/09031936.00090608","article-title":"Pulmonary veno-occlusive disease","volume":"33","author":"Montani","year":"2009","journal-title":"Eur Respir J"},{"issue":"6","key":"10.1016\/j.ccm.2013.08.003_bib70","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1136\/thx.32.6.763","article-title":"Familial pulmonary veno-occlusive disease: a case report","volume":"32","author":"Voordes","year":"1977","journal-title":"Thorax"},{"issue":"4","key":"10.1016\/j.ccm.2013.08.003_bib71","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/MD.0b013e31818193bb","article-title":"Pulmonary veno-occlusive disease: clinical, functional, radiologic, and hemodynamic characteristics and outcome of 24 cases confirmed by histology","volume":"87","author":"Montani","year":"2008","journal-title":"Medicine (Baltimore)"},{"issue":"6","key":"10.1016\/j.ccm.2013.08.003_bib72","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1164\/rccm.200208-861OC","article-title":"Pulmonary veno-occlusive disease caused by an inherited mutation in bone morphogenetic protein receptor II","volume":"167","author":"Runo","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.ccm.2013.08.003_bib73","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/j.1365-2559.1978.tb01734.x","article-title":"Capillary haemangiomatosis of the lungs","volume":"2","author":"Wagenvoort","year":"1978","journal-title":"Histopathology"},{"issue":"2","key":"10.1016\/j.ccm.2013.08.003_bib74","doi-asserted-by":"crossref","first-page":"106","DOI":"10.7326\/0003-4819-109-2-106","article-title":"Familial pulmonary capillary hemangiomatosis resulting in primary pulmonary hypertension","volume":"109","author":"Langleben","year":"1988","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ccm.2013.08.003_bib75","article-title":"EIF2AK4 mutations in pulmonary capillary hemangiomatosis","author":"Best","year":"2013","journal-title":"CHEST"},{"issue":"6","key":"10.1016\/j.ccm.2013.08.003_bib76","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1378\/chest.06-2674","article-title":"Medical therapy for pulmonary arterial hypertension: updated ACCP evidence-based clinical practice guidelines","volume":"131","author":"Badesch","year":"2007","journal-title":"Chest"},{"issue":"6","key":"10.1016\/j.ccm.2013.08.003_bib77","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1183\/09031936.00185011","article-title":"Pre-implantation genetic diagnosis in pulmonary arterial hypertension due to BMPR2 mutation","volume":"39","author":"Frydman","year":"2012","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ccm.2013.08.003_bib78","unstructured":"An act to prohibit discrimination on the basis of genetic information with respect to health insurance and employment: Wikipedia, 2008; Public Law enacted by the 110th United States Congress. Available at http:\/\/en.wikipedia.org\/wiki\/Genetic_Information_Nondiscrimination_Act. Accessed October 10, 2013."},{"issue":"2\u20133","key":"10.1016\/j.ccm.2013.08.003_bib79","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0014-2999(00)00810-4","article-title":"The interface between pharmacoepidemiology and\u00a0pharmacogenetics","volume":"410","author":"Maitland-van der Zee","year":"2000","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"10.1016\/j.ccm.2013.08.003_bib80","first-page":"228","article-title":"Pulmonary arterial hypertension","volume":"12","author":"Murali","year":"2006","journal-title":"Curr Opin Crit Care"}],"container-title":["Clinics in Chest Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272523113001032?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272523113001032?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T00:50:33Z","timestamp":1759452633000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272523113001032"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":80,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S0272523113001032"],"URL":"https:\/\/doi.org\/10.1016\/j.ccm.2013.08.003","relation":{},"ISSN":["0272-5231"],"issn-type":[{"value":"0272-5231","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetics of Pulmonary Arterial Hypertension","name":"articletitle","label":"Article Title"},{"value":"Clinics in Chest Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ccm.2013.08.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}